FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our
"Question of the Day" right now.
TRADER RADAR Which stock should be on your screen? Follow the clues to solve this puzzle.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
EMERGING MONEY TOP 20
Fast Money's index for the world.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
 |
Uncertain investors are looking to the Yahoo! (YHOO) board meeting next Friday for answers to the Microsoft (MSFT) bid. Will Yahoo accept or fight?
Even if there’s no other bidder, I think there’s potential for YHOO to get a higher bid just to get the deal to go through, says Pete Najarian.
I own YHOO says Karen Finerman. In my experience the first bid is never what you end up with. Yahoo is defenseless. And I’m long Microsoft too.
I think MSFT at $29 is cheap, says Guy Adami.
Amen to that, Macke adds.
#2 - The Japan Scenario
Comparisons between the US financial crisis and Japan's '90s slump abound ahead of G7 meeting in Tokyo. Can you trade it?
Japan waited about 2 years too long to lower interest rates, says Guy Adami, and the consequences were severe.
I think the Fed knows that and I expect they will remain aggressive with interest rates. If I’m right it should set up a great third and fourth quarters for US banks. Put Wachovia (WB), Citigroup (C), and Bank of America (BAC) on your radar, Adami counsels.
#3 – A Short In The Arm
What's the drug trade ahead of Schering-Plough earnings Tuesday before the bell?
Brian Schaeffer, Managing Director at VDM Capital joins the panel for this conversation. Following is a summary of his main points.
I think big cap pharma is a relatively safe place for your money if the economy slides into recession,” says Schaeffer.
In the space I like Pfizer (PFE), Schaeffer says, which was beat up pretty badly in 07' because of a depleted pipeline. This year I’m optimistic that their HIV studies could yield some effective new drugs. And I like their dividend.
I agree says Pete Najarian. I also like Pfizer (PFE), however I think they need to make an acquisition.
Schering-Plough (SGP) reports next week, adds Schaeffer, and there aren’t a lot of expectations after the disappointing results from the Vytorin and Zocor studies. I think it’s trading at a very attractive multiple however their yield is the lowest in the group.
Check Out These Other Posts |
______________________________________________________
Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to .
Trader disclosure: On Feb.8, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (INTC), (YHOO), (DIS); Najarian Owns (AMR), (C), (CSCO), (EBAY), (MCD), (MS), (MSFT), (XLF), (YHOO), (BIIB); Najarian Owns (FRE) Puts, (AIG) Puts; Najarian Owns (CNET) Calls, (AAPL) Calls, (NWA) Calls, (SKS) Calls; Finerman Owns (GS); Finerman's Firm Owns (GE), (JCP), (MSFT), (SKS), (WMT), (YHOO), (AAPL), (MO); Finerman's Firm Is Short (IWM), (IJR), (IYR), (MDY), (SPY), (COF); Finerman's Firm Is Short (LEH) And Owns (LEH) Puts; Finerman's Firm Owns (CROX) And (CROX) Calls, ; Finerman Owns (CROX) And (CROX) Calls; Finerman's Firm Is Short (RTH), (SPG), (TCO); Schaeffer Owns (PFE), (DHR), (GE)
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes